pregnanolone has been researched along with bromodeoxyuridine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ball, BG; Brinton, RD; Johnston, PB; Wang, JM | 1 |
| Bigler, S; Brinton, RD; Farley, JM; Ou, X; Stockmeier, C; Sun, C; Wang, JM | 1 |
| Bauer, G; Brinton, RD; Irwin, RW; Loya, CM; Rodgers, KE; Rogawski, MA; Salituro, FG; Solinsky, CM | 1 |
3 other study(ies) available for pregnanolone and bromodeoxyuridine
| Article | Year |
|---|---|
The neurosteroid allopregnanolone promotes proliferation of rodent and human neural progenitor cells and regulates cell-cycle gene and protein expression.
Topics: Analysis of Variance; Animals; Blotting, Western; Bromodeoxyuridine; Cell Count; Cell Cycle Proteins; Cell Proliferation; Cells, Cultured; Embryo, Mammalian; Female; Flow Cytometry; Gene Expression; Glial Fibrillary Acidic Protein; Green Fluorescent Proteins; Hippocampus; Humans; Immunohistochemistry; Intermediate Filament Proteins; Male; Microtubule-Associated Proteins; Myelin Basic Protein; Nerve Tissue Proteins; Nestin; Neurons; Oligonucleotide Array Sequence Analysis; Pregnancy; Pregnanolone; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stem Cells; Thymidine; Time Factors; Transfection; Tritium | 2005 |
Allopregnanolone increases the number of dopaminergic neurons in substantia nigra of a triple transgenic mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Analysis of Variance; Anesthetics; Animals; Bromodeoxyuridine; Cell Count; Disease Models, Animal; Dopaminergic Neurons; Humans; Mice; Mice, Transgenic; Mutation; Pregnanolone; Presenilin-1; Substantia Nigra; tau Proteins; Tyrosine 3-Monooxygenase | 2012 |
Allopregnanolone preclinical acute pharmacokinetic and pharmacodynamic studies to predict tolerability and efficacy for Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Biomarkers; Brain; Bromodeoxyuridine; Cell Differentiation; Cyclic AMP Response Element-Binding Protein; Cyclodextrins; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Evaluation, Preclinical; Female; Humans; Male; Maximum Tolerated Dose; Mice, Inbred C57BL; Mice, Transgenic; Neurogenesis; No-Observed-Adverse-Effect Level; Phosphorylation; Pregnanolone; Proliferating Cell Nuclear Antigen; Rabbits; Rats, Sprague-Dawley; Treatment Outcome | 2015 |